+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A validated risk score predicts the development of congestive heart failure and correlates with B-type natriuretic peptide after presentation with unstable angina or non-ST elevation myocardial infarction Results from OPUS-TIMI 16 and TIMI 11B



A validated risk score predicts the development of congestive heart failure and correlates with B-type natriuretic peptide after presentation with unstable angina or non-ST elevation myocardial infarction Results from OPUS-TIMI 16 and TIMI 11B



Circulation 106(19 Suppl.): II 402




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034331285

Download citation: RISBibTeXText


Related references

Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18. American Heart Journal 148(1): 173-180, 2004

Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. Journal of the American College of Cardiology 41(8): 1264-1272, 2003

Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry. American Journal of Cardiology 90(3): 303-305, 2002

Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial. American Heart Journal 157(4): 673-9.E1, 2009

A prospective evaluation of the TIMI risk score for unstable angina and non-ST-elevation myocardial infarction. Circulation 104(17 Suppl.): II 728, 2001

TIMI risk score underestimates prognosis in unstable angina/non-ST segment elevation myocardial infarction. Acute Cardiac Care 10(1): 26-29, 2008

Validation of the Thrombolysis In Myocardial Infarction risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry. American Journal of Cardiology 90(3): 303-305, 2002

Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score. Clinica Chimica Acta; International Journal of Clinical Chemistry 382(1-2): 106-111, 2007

Can risk stratification using TIMI score of unstable angina/non-ST elevation myocardial infarction predict short-term outcome after percutaneous coronary intervention?. Journal of the American College of Cardiology 39(5 Suppl. A): 39A, 2002

Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty. International Journal of Cardiology 115(3): 386-390, 2007

B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. Journal of the American College of Cardiology 44(2): 335-339, 2004

N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction. Heart 94(1): 40-43, 2008

Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial. Circulation 109(7): 874-880, 2004

Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction. American Journal of Cardiology 94(9): 1113-1117, 2004